Peter Riedell News Today

CHICAGO, IL / ACCESSWIRE / January 22, 2024 / The American Society for Transplantation and Cellular Therapy (ASTCT), the Association of American Cancer Institutes (AACI), and the Association of Community Cancer Centers (ACCC) recently announced the RECUR initiative. The initiative is a collaboration among these orga...

ASTCT, the Association of Community Cancer Centers (ACCC) and the AACI have launched the RECUR initiative to improve patient access to CAR T therapy.

ASTCT, AACI, and ACCC Launch RECUR Initiative to Enhance Patient Access ...

Amy W. Zhou, MD, highlights the unique mechanism of action of the JAK1/2 and ACVR1 inhibitor momelotinib and the importance of ongoing investigations of JAK inhibitor combination therapies in myelofibrosis.

Hans Schreiber, MD, PhD, was recognized for his dedication and significant contributions to the promising field of cellular immunotherapy for cancer treatment.